Synchrony Financial Investing Cash Flow increased by 132.8% to $1.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 57.7%, from $3.60B to $1.52B. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows an upward trend with a -22.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.76B | $1.82B | -$1.05B | -$4.14B | -$6.86B | $692.00M | -$5.19B | -$2.57B | -$7.17B | $798.00M | -$2.51B | -$2.23B | -$4.96B | $3.60B | -$2.24B | -$1.57B | -$4.64B | $1.52B |
| QoQ Change | — | +131.5% | -157.9% | -293.7% | -65.6% | +110.1% | -849.9% | +50.5% | -179.2% | +111.1% | -414.2% | +11.0% | -122.5% | +172.6% | -162.2% | +29.8% | -194.9% | +132.8% |
| YoY Change | — | — | — | — | -19.0% | -61.9% | -393.3% | +38.0% | -4.5% | +15.3% | +51.7% | +13.1% | +30.8% | +351.5% | +10.6% | +29.4% | +6.5% | -57.7% |